TUCSON, Ariz.--(BUSINESS WIRE)--SynCardia Systems, Inc., manufacturer of the world’s only FDA- and CE Mark-approved temporary Total Artificial Heart (TAH-t), is announcing the availability for clinical investigation of a portable driver that is designed to allow stable U.S. patients to recover at home while they wait for their donor heart for transplant.
“The Companion Driver is the first pulsatile driver intended to fully support patients from implant through discharge and back to the hospital for transplant,” explains SynCardia’s CEO and President, Rodger G. Ford.
